Torrent Pharmaceuticals

TORNTPHARM · NSE · INR

4767,30 ₹Variación respecto al cierre anterior: −0,68 %Variación absoluta: −32,70 ₹

Cierre · 1 de octubre de 2026

Perfil de la empresa

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Descripción disponible en inglés.

Datos societarios

Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
País
India
Sede
Avirat, Thaltej Shilaj Road, 380059, Ahmedabad
Empleados
18.258
Cotización
TORNTPHARM · NSE
Divisa
INR
ISIN
INE685A01028